Pay in 4 interest-free payments of $7.30 Learn more
Ships within 48 hours · Estimated delivery Aug 30 - Sep 4
Subcutaneous batoclimab in generalized myasthenia gravis: results from a phase 2a trial with an open-label extension
For patients seeking lasting change, GLP-1 therapy stands apart from outdated, unsustainable alternatives
If the cost of beef continues to climb, this would rise to 37% in the long run
Starting dose (2.5mg) At the 2.5mg starting dose , most people experience the least severe GI side effects
Studies of other GLP-1 receptor agonists provide relevant context
US$ 25.89
US$ 21.49
US$ 25.69
US$ 20.18
